Sun Pharmaceuticals to acquire minority stake in Agatsa Software and Remidio Innovative Solutions
Agasta Software is engaged in research, development and commercialization of medical devices
Agasta Software is engaged in research, development and commercialization of medical devices
Cipla has received 8 inspectional observations in Form 483
Canagliflozin and Metformin Hydrochloride Tablets had annual sales of US $49.4 million in the United States
Strategic partnership aims to support significant growth of the Ibuprofen product market in Brazil and is backed by Univar Solutions' state-of-the-art Solution Center in São Paulo, Brazil
The Tc 99m Mertiatide Injection is used in the diagnosis of congenital and acquired renal abnormalities
Cell sorting technology supports researchers advancing new therapies
Granules now have a total of 53 ANDA approvals from USFDA
The product will be manufactured at the plant of Bell, Sons & Co. (Druggists) Ltd. located at Gifford House, Slaidburn Crescent, Southport, UK
The issue with a face value of Rs 10 per equity share consists of a fresh issue of equity shares worth up to Rs 400 crore
The company has been issued ‘Form 483’ with two observations
Subscribe To Our Newsletter & Stay Updated